Weikert S - Search Results

1

Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.

Christoph F, Kempkensteffen C, Weikert S, Köllermann J, Krause H, Miller K, Schostak M, Schrader M. Christoph F, et al. Among authors: weikert s. Br J Cancer. 2006 Dec 18;95(12):1701-7. doi: 10.1038/sj.bjc.6603482. Epub 2006 Nov 28. Br J Cancer. 2006. PMID: 17133271 Free PMC article.

2

Frequent epigenetic inactivation of p53 target genes in seminomatous and nonseminomatous germ cell tumors.

Christoph F, Kempkensteffen C, Weikert S, Krause H, Schostak M, Miller K, Schrader M. Christoph F, et al. Among authors: weikert s. Cancer Lett. 2007 Mar 8;247(1):137-42. doi: 10.1016/j.canlet.2006.03.028. Epub 2006 May 11. Cancer Lett. 2007. PMID: 16697107

3

EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.

Hinz S, Kempkensteffen C, Weikert S, Schostak M, Schrader M, Miller K, Christoph F. Hinz S, et al. Among authors: weikert s. Tumour Biol. 2007;28(3):151-7. doi: 10.1159/000103380. Epub 2007 Jun 1. Tumour Biol. 2007. PMID: 17541304

4

Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance.

Hinz S, Kempkensteffen C, Christoph F, Krause H, Schrader M, Schostak M, Miller K, Weikert S. Hinz S, et al. Among authors: weikert s. Tumour Biol. 2008;29(5):323-9. doi: 10.1159/000170879. Epub 2008 Nov 5. Tumour Biol. 2008. PMID: 18984978

5

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

Weikert S, Christoph F, Schrader M, Krause H, Miller K, Müller M. Weikert S, et al. Int J Cancer. 2005 Aug 10;116(1):100-4. doi: 10.1002/ijc.21000. Int J Cancer. 2005. PMID: 15761870

6

The inhibitor of apoptosis (IAP) survivin is expressed in human testicular germ cell tumors and normal testes.

Weikert S, Schrader M, Krause H, Schulze W, Müller M, Miller K. Weikert S, et al. Cancer Lett. 2005 Jun 8;223(2):331-7. doi: 10.1016/j.canlet.2004.10.038. Epub 2004 Dec 8. Cancer Lett. 2005. PMID: 15896468

7

Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.

Weikert S, Krause H, Wolff I, Christoph F, Schrader M, Emrich T, Miller K, Müller M. Weikert S, et al. Int J Cancer. 2005 Nov 1;117(2):274-80. doi: 10.1002/ijc.21168. Int J Cancer. 2005. PMID: 15900578

8

Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas.

Weikert S, Christoph F, Köllermann J, Müller M, Schrader M, Miller K, Krause H. Weikert S, et al. Int J Mol Med. 2005 Aug;16(2):349-53. Int J Mol Med. 2005. PMID: 16012774

9

Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.

Christoph F, Weikert S, Wolff I, Schostak M, Tabiti K, Müller M, Miller K, Schrader M. Christoph F, et al. Among authors: weikert s. Cancer Lett. 2007 Jan 8;245(1-2):121-6. doi: 10.1016/j.canlet.2005.12.038. Epub 2006 Feb 13. Cancer Lett. 2007. PMID: 16473461

10

Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.

Christoph F, Weikert S, Kempkensteffen C, Krause H, Schostak M, Miller K, Schrader M. Christoph F, et al. Among authors: weikert s. Int J Cancer. 2006 Sep 15;119(6):1396-402. doi: 10.1002/ijc.21971. Int J Cancer. 2006. PMID: 16642478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters